代谢
/丙二醇, 1,2-二硝酸盐/ (PGDN) 的代谢,在体外血液中以及大鼠体内的实验显示,50% 在 1 小时内分解,剩余的 50% 在接下来的小时内分解。在血液中孵育时产生了少量的无机亚硝酸盐,而有积累的无机硝酸盐。在 3 小时结束时,第一次测量时,发现了大量的丙二醇 2-单硝酸盐 (PGMN-2),以及少量的 PGMN-1)。单硝酸盐、无机硝酸盐和亚硝酸盐的总和代表了加入血液的初始量的 95%。这种代谢发生在红细胞中。在完整的大鼠体内,与体外血液中的情况不同,单硝酸盐进一步降解为除了单硝酸盐和无机硝酸盐之外的氮化合物。只有 56% 的给药 PGDN 以无机硝酸盐的形式出现在尿液中。因此,从定性上来说,PGDN 的体内外代谢与/乙二醇二硝酸盐/ (EGDN) 的代谢没有太大区别。唯一的区别是 PGDN 产生两种单硝酸盐,且 2-异构体占主导,而 EGDN 只产生/乙二醇单硝酸盐/。从数量上来说,皮下注射 PGDN 后血液中的二硝酸盐和无机亚硝酸盐含量比同等剂量的 EGDN 注射要少。在大鼠皮下注射 65 mg/kg 的 PGDN 后,24 小时内排泄完全。
The metabolism of /propylene glycol, 1,2-dinitrate/ (PGDN), as determined in vitro in blood and in vivo in rats, showed that 50% was broken down in 1 hr, and 50% of the remainder in the following hour. Small concentrations of inorganic nitrite were produced during incubation in blood, whereas inorganic nitrate accumulated. At the end of 3 hr, the first time it was measured, there were large amounts of propylene glycol 2-mononitrate (PGMN-2), together with small amounts of PGMN-1). The summed quantities of mononitrates, inorganic nitrate, and nitrite represented 95% of the initial amount added to blood. this metabolism occurred in the erythrocytes. In the intact rat, in contrast to in vitro in the blood, mononitrates undergo further degradation to nitrogen compounds other than the mononitrates and inorganic nitrate. Only 56% of the administered PGDN appeared in the urine as inorganic nitrate. THus, there is qualitatively little to distinguish the in vitro and in vivo metabolism of PGDN from that of /ethylene glycol dinitrate/ (EGDN). The only difference is that PGDN gives rise to two mononitrates and the 2-isomer is predominant, whereas EGDN gives rise only to /ethylene glycol mononitrate/. Quantitatively, there is less dinitrate and inorganic nitrite in the bloodstream after subcutaneous injection from PGDN than from a comparable injection of EGDN. Excretion was complete in 24 hr following a 65 mg/kg PGDN subcutaneous injection in rats.
来源:Hazardous Substances Data Bank (HSDB)